Amalgamated Bank Point Biopharma Global Inc. Transaction History

Amalgamated Bank

  • $12.1 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
SELL
$6.86 - $10.86 $21,739 - $34,415
-3,169 Reduced 26.38%
8,845 $80,000
Q1 2023

May 02, 2023
SELL
$6.78 - $8.1 $18,116 - $21,643
-2,672 Reduced 18.19%
12,014 $87,000
Q4 2022

Feb 10, 2023
BUY
$5.72 - $9.78 $16,891 - $28,880
2,953 Added 25.17%
14,686 $107,000
Q3 2022

Nov 09, 2022
BUY
$7.24 - $10.31 $1,274 - $1,814
176 Added 1.52%
11,733 $91,000
Q2 2022

Aug 15, 2022
BUY
$5.6 - $9.5 $64,719 - $109,791
11,557 New
11,557 $79,000

Others Institutions Holding PNT

# of Institutions
1
Shares Held
20K
Call Options Held
0
Put Options Held
0
View Full List

About POINT Biopharma Global Inc.

PNT Quotes by TradingView
  • Ticker PNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,025,000
  • Description
  • POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...
More about PNT
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email